| 701 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Adverse Childhood Experiences and Adult Smoking, Nebraska, 2011 - CDC |
Smoking is a public health risk; the prevalence of smoking among adults in Nebraska is 18.4%. Studies indicate that maltreatment of children alters their brain development, possibly increasing risk for tobacco use. |
| individual ACE analysis | 0.283874 |
| childhood maltreatment | 0.346918 |
| ACE data analysis | 0.314676 |
| adverse health trajectories | 0.263232 |
| ACE prevalence | 0.290845 |
| direct ACE categories | 0.294144 |
| direct ACE | 0.305367 |
| environmental ACE exposures | 0.310692 |
| childhood sexual abuse | 0.301403 |
| early health determinants | 0.263958 |
| ACE status | 0.258441 |
| ACE module | 0.386275 |
| environmental ACE groups | 0.290207 |
| individual ACE categories | 0.296657 |
| childhood experience exposures | 0.274651 |
| childhood adverse events | 0.274202 |
| physical abuse | 0.292144 |
| ACE categories | 0.361554 |
| child abuse | 0.388252 |
| mental illness | 0.30846 |
| verbal abuse | 0.326219 |
| household member | 0.266113 |
| Nebraska residents | 0.255933 |
| environmental ACEs | 0.584871 |
| environmental ACE categories | 0.327508 |
|
| persons | 0.31425 |
| household substance abuse | 0.268586 |
| adverse health determinants | 0.266915 |
| adverse childhood experiences | 0.932618 |
| individual ACE | 0.500234 |
| Childhood Experiences Study | 0.34465 |
| Nebraska BRFSS ACE | 0.286653 |
| following ACE categories | 0.27397 |
| adverse childhood events | 0.310139 |
| smoking | 0.367618 |
| state-specific ACE data | 0.27648 |
| substance abuse | 0.357881 |
| specific individual ACE | 0.369511 |
| public health | 0.268728 |
| Felitti VJ | 0.282812 |
| household mental illness | 0.286119 |
| direct ACEs | 0.399053 |
| health | 0.343604 |
| adverse events | 0.29816 |
| individual ACE exposures | 0.310374 |
| et al | 0.306519 |
| individual ACEs | 0.378365 |
| adverse childhood experience | 0.41376 |
| individual ACE category | 0.271947 |
|
CLICK HERE |
| 4421 |
Centers for Disease Control and Prevention |
Html |
en |
Diseases & Conditions A-Z Index - J |
CDC Diseases and Conditions A-Z Index |
| MPEG | 0.741242 |
| site | 0.541063 |
| PDF | 0.544429 |
|
|
CLICK HERE |
| 4549 |
Centers for Disease Control and Prevention |
Html |
en |
Influenza (Flu) Antiviral Medications |
Information about influenza antiviral use for the flu season for health care providers - CDC |
| CDC Health Alert | 0.614564 |
| Chemoprophylaxis | 0.322473 |
| 2016-2017 influenza season | 0.774044 |
| clinical practice | 0.461616 |
| Viruses | 0.327587 |
| recommendations | 0.361857 |
| CDC Health Advisory | 0.600353 |
| Immunization Practices | 0.459339 |
| Possible Flu | 0.447522 |
| Advisory Committee | 0.441861 |
| password | 0.325383 |
| pages | 0.321788 |
| Clinicians | 0.334965 |
| influenza antiviral medications | 0.907559 |
| MB | 0.332376 |
| ACIP | 0.360054 |
|
| CDC Expert Commentary | 0.617489 |
| current summary | 0.447114 |
| High-Risk Patient | 0.456562 |
| PDF Version | 0.440472 |
| Antiviral Agents | 0.60671 |
| 00PM ET | 0.451583 |
| list | 0.323151 |
| Medscape | 0.340604 |
| page contain excerpts | 0.573754 |
| Treatment | 0.322508 |
| Drifted Influenza | 0.600549 |
| Antiviral Guide References | 0.736605 |
| Antivirals | 0.321629 |
| Links | 0.322701 |
| information | 0.325471 |
| related references | 0.446716 |
|
CLICK HERE |
| 4577 |
Centers for Disease Control and Prevention |
Html |
en |
CDC H1N1 Flu | Considerations Regarding Novel H1N1 Flu Virus in Obstetric Settings |
null |
| newborn nursery | 0.521499 |
| H1N1 virus-infected mother | 0.282298 |
| H1N1 influenza virus | 0.788285 |
| newborn care settings | 0.362161 |
| immediate postpartum period | 0.260026 |
| infection control policies | 0.35356 |
| hygiene/ cough etiquette | 0.24276 |
| symptom onset | 0.205455 |
| infection control | 0.806365 |
| mother | 0.822714 |
| infection control guidance | 0.471434 |
| pregnant women | 0.365917 |
| healthy term | 0.267379 |
| influenza virus infection | 0.764529 |
| H1N1 virus exposure | 0.232677 |
| standard precautions | 0.435137 |
| respiratory secretions | 0.313615 |
| close contact | 0.447557 |
| newborn baby | 0.220267 |
| newborn nursery setting | 0.399295 |
|
| Standard precautions Infection | 0.242717 |
| newborn care | 0.434733 |
| current infection control | 0.334452 |
| newborn infant | 0.331883 |
| cough etiquette guidelines | 0.239057 |
| seasonal influenza | 0.292519 |
| newborn care hospitals | 0.320012 |
| respiratory hygiene/ cough | 0.257504 |
| Newborn infants | 0.259326 |
| newborn nurseries | 0.222151 |
| virus infection | 0.921643 |
| H1N1 virus infection | 0.805621 |
| newborn ward configuration | 0.323926 |
| newborn protection | 0.234081 |
| newborn follow-up | 0.231754 |
| term newborn nursery | 0.397985 |
| H1N1 Flu Virus | 0.228941 |
| droplet exposure | 0.221475 |
| healthy term newborns | 0.253463 |
|
CLICK HERE |
| 7920 |
Centers for Disease Control and Prevention |
Html |
en |
Serogroup A Meningococcal Conjugate Vaccine Coverage Afterthe First National Mass Immunization Campaign - Burkina Faso,2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| Meningitis Vaccine Project | 0.660945 |
| PsA-TT vaccination coverage | 0.682234 |
| epidemic meningitis | 0.656319 |
| du Burkina Faso | 0.764911 |
| vaccination coverage | 0.712073 |
| vaccination card | 0.687475 |
| routine immunization | 0.659201 |
| new serogroup | 0.656393 |
| vaccination campaign | 0.678204 |
| Meningococcal meningitis epidemics | 0.662017 |
| high coverage | 0.650244 |
| high vaccine coverage | 0.667332 |
| campaign-eligible persons | 0.647825 |
| national routine immunization | 0.655151 |
| age groups | 0.703808 |
| Burkina Faso Ministry | 0.780759 |
| successful introduction | 0.653031 |
| national mass-immunization campaign | 0.65751 |
| persons | 0.663807 |
| Vaccination status | 0.648667 |
| Burkina Faso experience | 0.755094 |
| mass immunization campaign | 0.724459 |
| high vaccination coverage | 0.679757 |
| vaccination | 0.713268 |
| National coverage | 0.657285 |
|
| high PsA-TT coverage | 0.66236 |
| periodic mass campaigns | 0.65607 |
| Lutte Contre la | 0.671786 |
| SantУЉ du Burkina | 0.715145 |
| vaccination coverage estimates | 0.703762 |
| new vaccine | 0.664673 |
| PsA-TT coverage | 0.686566 |
| sub-Saharan Africa | 0.682341 |
| Reliable vaccination coverage | 0.674236 |
| meningococcal conjugate vaccine | 0.720916 |
| Overall administrative coverage | 0.649379 |
| meningitis disease rates | 0.649602 |
| Accurate vaccination coverage | 0.690463 |
| coverage | 0.739151 |
| successful vaccination campaigns | 0.658516 |
| target population | 0.647756 |
| administrative coverage | 0.656681 |
| campaign coverage | 0.650072 |
| PsA-TT campaign | 0.649789 |
| meningococcal meningitis | 0.712236 |
| Contre la Maladie | 0.670073 |
| mass vaccination | 0.648306 |
| Burkina Faso | 0.985245 |
| meningitis belt | 0.69334 |
|
CLICK HERE |
| 7993 |
Centers for Disease Control and Prevention |
Html |
es |
Preventing Chronic Disease - CDC: Volume 10, 2013: 11_0339 |
Volumen 10 — el 03 de enero de 2013. |
| Guéye S | 0.535739 |
| pequeño tamaño | 0.463577 |
| Seck SM | 0.55034 |
| metabólicas crónicas | 0.537436 |
|
| salud pública | 0.873817 |
| Tamba K | 0.553518 |
| Ba I | 0.540121 |
| trabajadores senegaleses | 0.940807 |
|
CLICK HERE |
| 11260 |
Centers for Disease Control and Prevention |
Html |
es |
Alta actividad deinfluenza en todo el país |
El nivel de actividad de la influenza permanece alto y las hospitalizaciones y muertes relacionadas con esta enfermedad siguen registrando notables aumentos entre las personas de edad avanzada. Es especialmente importante que las personas que corren mayores riesgos de complicaciones a causa de la influenza se vacunen, tomen medidas preventivas y usen medicamentos antivirales cuando se los receten |
| Archivo Apple Quicktime | 0.457612 |
| Archivo RealPlayer | 0.437473 |
| alto riesgo | 0.904566 |
| Archivo Microsoft PowerPoint | 0.463678 |
| Archivo Adobe PDF | 0.457587 |
| tomen medidas | 0.578652 |
| mayores riesgos | 0.444249 |
| Archivo Microsoft | 0.553771 |
|
| Archivo Microsoft Word | 0.462879 |
| notables aumentos | 0.449807 |
| siguientes medidas | 0.461537 |
| Archivo Zip Comprimido | 0.456963 |
| Archivo Microsoft Excel | 0.458186 |
| gotitas respiratorias | 0.446025 |
| cepa h3n2 | 0.444547 |
|
CLICK HERE |
| 12055 |
Centers for Disease Control and Prevention |
Html |
en |
Evidence for Declining Numbers of Ebola Cases - MontserradoCounty, Liberia, June-October 2014 |
On November 14, 2014, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr). |
| negative Ebola test | 0.874137 |
| Ebola treatment unit | 0.871763 |
| Red Cross | 0.748486 |
| County Health Department | 0.73367 |
| ETU-documented negative RT-PCR | 0.828305 |
| number | 0.716311 |
| Ebola victims | 0.800742 |
| MMWR Early Release | 0.723331 |
| unique identifier | 0.719646 |
| County Community Health | 0.743273 |
| Ebola transmission | 0.798739 |
| laboratory results | 0.722938 |
| ETU admissions | 0.956151 |
| consecutive negative Ebola | 0.849728 |
| ETU admission data | 0.851267 |
| Ebola-related dead bodies | 0.72966 |
| negative Ebola RT-PCR | 0.959591 |
| data sources | 0.782028 |
| Ebola-positive RT-PCR test | 0.77156 |
| test results | 0.956919 |
| routine data collection | 0.72167 |
| RT-PCR test result | 0.840449 |
| Laboratory test results | 0.74851 |
| Tolbert G. Nyenswah | 0.721406 |
|
| available ETU beds | 0.748564 |
| Ebola-positive test results | 0.737095 |
| Ebola RT-PCR test | 0.923205 |
| Ebola test result | 0.923288 |
| Ebola patients | 0.825972 |
| Ebola | 0.981733 |
| Ebola virus disease | 0.871646 |
| Ebola epidemic | 0.829902 |
| Amanda Ashraf Kamali | 0.718961 |
| patient blood samples | 0.740441 |
| Ebola cases | 0.888949 |
| RT-PCR test results | 0.939758 |
| Ebola case | 0.806797 |
| Island Clinic ETU | 0.742845 |
| positive RT-PCR test | 0.788206 |
| Ebola risks | 0.797121 |
| negative RT-PCR test | 0.838543 |
| John M. Aberle-Grasse | 0.722253 |
| non-ETU health facilities | 0.717618 |
| Montserrado County | 0.965519 |
| Red Crescent Societies | 0.792456 |
| positive Ebola test | 0.878505 |
| ETU documentation | 0.758695 |
| dead bodies | 0.861153 |
|
CLICK HERE |
| 12502 |
Centers for Disease Control and Prevention |
Video |
en |
June 2014 ACIP Meningococcal Vaccines, Vaccine Supply, Hep Vaccines & Public Comment |
Introduction, Epidemiology of Meningococcal Disease Outbreaks in the United States, Interim Guidance for the Use of a Serogroup B Meningococcal Vaccine Under a CDC-Sponsored Expanded Access IND, Vaccine supply update, and Hepatitis Vaccines.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://streaming.cdc.gov/vod.php?id=9468e3bd2aa541d048a4b78d82e74e0820140728124620079 |
| Public Comment | 0.530103 |
| ACIP Meningococcal Vaccines | 0.981329 |
|
| Vaccine Supply | 0.556786 |
| Hep Vaccines | 0.798621 |
|
CLICK HERE |
| 13192 |
Centers for Disease Control and Prevention |
Html |
en |
H5 Information for Specific Groups |
Information for Specific Groups related to H5 influenza viruses - CDC |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |